CSNK2B and non-small cell lung carcinoma: In summary, the above results suggest that CK2B expression in CD8+ T cells from NSCLC patients is favorably correlated with T cell exhaustion and unfavorably correlated with the efficacy of anti‐PD‐1 therapy.